High Sensitivity CRP (hsCRP) in addition to lipid evaluation and risk scoring systems helps in the assessment of cardiovascular disease (CVD) risk.
The American Heart Association (AHA) and Centre for Disease Control and Prevention (CDC) now recommend the use of hsCRP as a more sensitive marker of CVD risk compared to traditional CRP assays. The hsCRP assay is particularly useful in predicting future cardiac events in individuals with no previous history of CVD. Healthy individuals with CRP levels higher than 3mg/l are 2 to 4 times more likely to have a heart attack or stroke.
Approximately half of all heart attacks occur in patients who have a normal lipid profile and are classified as low risk based on traditional methods of risk estimation. The measurement of hsCRP can therefore help clinicians to identify these individuals earlier; it can also be used to evaluate the risk of a recurrent cardiac event. In high risk groups there have even been indications that CRP could be used as a prognostic tool. AHA/CDC risk assessment guidelines: Low Risk <1mg/l Average Risk 1 – 3 mg/l High Risk >3mg/l The. Randox hsCRP assay is based on an immunoturbidimetric method. All reagents are liquid ready-to-use and suitable for use on a wide range of chemistry analysers.